Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Capital Expenditures (2024 - 2025)

Historic Capital Expenditures for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $2.6 million.

  • Kura Oncology's Capital Expenditures changed N/A to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year change of. This contributed to the annual value of $472000.0 for FY2024, which is 18095.24% up from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's Capital Expenditures is $2.6 million.
  • Kura Oncology's 5-year Capital Expenditures high stood at $2.6 million for Q3 2025, and its period low was $16000.0 during Q2 2024.